Astonea Labs Limited held its EGM on 27th March 2026 at Panchkula, Haryana, with 8 resolutions on the agenda.
Key resolution approved reallocation of unutilised IPO proceeds for equity acquisition in M/s Damaira Pharmaceuticals Pvt. Ltd.
Three material related party transaction approvals for FY 2026-27 were passed as Special Resolutions.
Filing made to BSE under Regulation 30 of SEBI LODR 2015 by Company Secretary Ankit Kapoor.